15-17 April, 2019

The Waldorf Hilton

London, UK


Mastermind & Expertise Partner

Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Driven by a passion for excellence and a relentless commitment to quality, we unlock opportunities that advance innovation and deliver on the promise of a healthier world.



Mastermind Partner

Accelerate your next breakthrough in diagnostics and therapeutics. Abcam’s comprehensive portfolio of high quality, customizable solutions are ideal for diagnostic and therapeutic applications. Our technical ability coupled with a flexible commercial approach enables us to deliver projects that will help achieve your goals


NeoGenomics Laboratories

Expertise Partner

NeoGenomics is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-licensed facilities across the U.S., but work hard to maintain easy access and all the efficiencies of a smaller operation.


Thermo Fisher Scientific

Expertise Partner

Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We support precision medicine from translational research to the development of companion diagnostics with innovative technologies and service through our Thermo Scientific, Applied Biosystems, Invitrogen, Gibco and Ion Torrent brands.


Guardant Health

Expertise Partner

Guardant Health is a pioneer in non-invasive cancer diagnostics, addressing challenges across the cancer care continuum. The company has raised more than $200 million from leading venture capital firms and in 2014 launched Guardant360, the first comprehensive liquid biopsy for clinical use. Guardant Health is improving therapy selection for advanced cancer patients across the globe using its proprietary cell-free circulating tumor DNA NGS platform. Guardant Health is partnered with biopharmaceutical companies to prospectively screen patients for trial enrollment, develop companion diagnostics to support clinical adoption, and use retrospective analysis for early insights into patient response and tumor evolution, as well as accelerate the development of new therapies.



Almac Diagnostic Services

Program Partner

Almac Diagnostic Services is a stratified medicine company specialising in biomarker driven clinical trials. Our diagnostic experience spans oncology, immunology, CNS and infective diseases. Our global laboratories, based in the UK and US offer tailored solutions from discovery to commercialisation: Biomarker discovery. Custom assay development & validation. DNA and RNA panel solutions. Flexible CDx development & commercialisation. Expert regulatory support. Bioinformatics & software development. Your Clinical Trial Diagnostic Partner.



Sysmex Inostics

Program Partner

Sysmex Inostics, a subsidiary of Sysmex Corporation, is a leader in blood-based molecular diagnostics testing in oncology.  Our highly sensitive OncoBEAM™ kits and tests offer a minimally-invasive alternative for the detection of cancer gene mutations, clinical trials testing and companion diagnostics development.



Program Partner

Biocartis aims to provide direct access to personalized medicine for patients worldwide by developing fully integrated and broadly applicable molecular diagnostics. Our platforms can be used in a wide variety of healthcare settings to enable rapid and high-quality care close to patients.


Q2 Solutions

Program Partner

Q2 Solutions is a leading global clinical trials laboratory services organization that partners with biopharmaceutical, medical device and diagnostics customers to transform science and data into actionable medical insights. Its laboratory services span the development lifecycle from Discovery through Clinical Trials to Commercialization that includes predictive biomarker solutions for Companion Diagnostics.




Program Partner

Invivoscribe is the worldwide leader in precision medicine and companion diagnostics (CDx) for hematological malignancies. Invivoscribe offers a full range of hematology-oncology testing products and services (B- and T-cell clonality, NGS gene panels, MRD assays, and comprehensive bioinformatics software), all developed under ISO 13485 design control and manufactured in our own cGMP facility. We also operate the Laboratories for Personalized Molecular Medicine (LabPMM), a global network of clinical reference labs with locations in the United States, Germany, and Japan. These laboratories offer an ever-expanding menu of internationally harmonized tests to support the stratification and enrollment of patients in clinical trials, optimized treatments, and development of CDx. We continually strive to provide access to accurate test results and improve the quality of healthcare worldwide



Spotlight Partner

BioIVT, formerly BioreclamationIVT, is a leading provider of control and disease state samples (human/animal tissues, cells, blood, biofluids). Our PHASEZERO team provides value-added services that evaluate the efficacy and safety of therapeutics. Combining technical expertise, exceptional customer service, and unparalleled access to biospecimens, BioIVT partners with scientists in ELEVATING SCIENCE.



Spotlight Partner

Ultivue is a venture-backed company developing reagent-driven solutions for high-performance biological imaging in situ, combining unlimited multiplexing at high speed with high spatial resolution. Ultivue’s proprietary solutions will enable researchers to realize the promise of personalized medicine. The company has launched products and services that will seamlessly integrate into existing workflows for biomarker discovery, assay validation, and companion diagnostic applications.




Panel Partner

We improve patient lives by unlocking the tissue phenome. Our work model builds on a simple premise: Tissue Phenomics strengthens results, from biomarker discovery to clinical development and meaningful diagnostics. We bring Tissue Phenomics to you, seamlessly integrate into your processes, and act as your reliable, science-driven partner along the way.



Panel Partner

Diaceutics is the diagnostic development and commercialization service provider. We have been leading this field for 13 years, entirely focused on the intersection between diagnostics and therapeutic decision making. We provide an end to end service that encompasses everything from understanding the diagnostic landscape to test implementation in treatment pathways. This is all enabled by a robust flow of data from our global laboratory network. Our ultimate goal is to drive better testing to enable better treatment decisions for patients.



Spotlight Partner

Oncoradiomics SA, is a spin-off artificial intelligence SME based in Liège (Belgium) that was founded in 2016. Oncoradiomics focuses on development of radiomics tools with the aim to provide clinicians and researchers deeper insight into the information embedded in medical images. Oncoradiomics first tool is an innovative imaging analysis software (RadiomiX Discovery ToolBox) enabling the extraction of unique quantitative image features from standard DICOM images. Radiomic signatures are developed thanks to these features and guide personalized diagnosis and treatment. All signatures are developed to answer unmet clinical needs and are validated, then certified (CE/FDA marked) and integrated into the RadiomiX Clinical platform. The RadiomiX Clinical platform is to be integrated into clinical practice and allows clinicians to easily benefit from A.I supported decisions.

Furthermore, the company has a unique privacy by design big data network (DistriM™) that allows users, thanks to distributed machine learning, to access data from other hospitals without the data ever leaving the firewalls of the institution: distributed learning for federated databases.


For further information please don’t hesitate to send us an email.